11-1246497-T-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_002458.3(MUC5B):āc.9617T>Cā(p.Ile3206Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0275 in 1,602,608 control chromosomes in the GnomAD database, including 962 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_002458.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MUC5B | NM_002458.3 | c.9617T>C | p.Ile3206Thr | missense_variant | 31/49 | ENST00000529681.5 | NP_002449.2 | |
MUC5B-AS1 | NR_157183.1 | n.56+3124A>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MUC5B | ENST00000529681.5 | c.9617T>C | p.Ile3206Thr | missense_variant | 31/49 | 5 | NM_002458.3 | ENSP00000436812.1 | ||
MUC5B-AS1 | ENST00000532061.2 | n.56+3124A>G | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0257 AC: 3764AN: 146234Hom.: 69 Cov.: 32
GnomAD3 exomes AF: 0.00969 AC: 2336AN: 240968Hom.: 112 AF XY: 0.00901 AC XY: 1177AN XY: 130582
GnomAD4 exome AF: 0.0277 AC: 40384AN: 1456240Hom.: 893 Cov.: 127 AF XY: 0.0272 AC XY: 19730AN XY: 724588
GnomAD4 genome AF: 0.0257 AC: 3763AN: 146368Hom.: 69 Cov.: 32 AF XY: 0.0261 AC XY: 1868AN XY: 71490
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at